US 12,251,128 B2
Endovascular devices and methods for exploiting intramural space
Chad J. Kugler, Buffalo, MN (US); Robert E. Atkinson, Lake Elmo, MN (US); and Matthew J. Olson, Grafton, ND (US)
Assigned to BOSTON SCIENTIFIC SCIMED, INC., Maple Grove, MN (US)
Filed by BOSTON SCIENTIFIC SCIMED, INC., Maple Grove, MN (US)
Filed on Feb. 8, 2023, as Appl. No. 18/107,109.
Application 18/107,109 is a continuation of application No. 17/021,111, filed on Sep. 15, 2020, granted, now 11,607,245.
Application 17/021,111 is a continuation of application No. 15/704,618, filed on Sep. 14, 2017, granted, now 10,806,487, issued on Oct. 20, 2020.
Application 15/704,618 is a continuation of application No. 14/553,069, filed on Nov. 25, 2014, granted, now 9,788,855, issued on Oct. 17, 2017.
Application 14/553,069 is a continuation of application No. 13/660,919, filed on Oct. 25, 2012, granted, now 8,961,494, issued on Feb. 24, 2015.
Application 13/660,919 is a continuation of application No. 11/518,430, filed on Sep. 11, 2006, granted, now 8,323,261, issued on Dec. 4, 2012.
Claims priority of provisional application 60/839,782, filed on Aug. 24, 2006.
Claims priority of provisional application 60/811,478, filed on Jun. 7, 2006.
Claims priority of provisional application 60/727,819, filed on Oct. 18, 2005.
Claims priority of provisional application 60/717,726, filed on Sep. 15, 2005.
Claims priority of provisional application 60/716,287, filed on Sep. 12, 2005.
Prior Publication US 2023/0190331 A1, Jun. 22, 2023
Int. Cl. A61B 17/34 (2006.01); A61B 17/00 (2006.01); A61B 17/22 (2006.01); A61B 17/221 (2006.01); A61B 17/32 (2006.01); A61B 17/3205 (2006.01); A61B 17/3207 (2006.01); A61F 2/88 (2006.01); A61M 25/00 (2006.01); A61M 25/01 (2006.01); A61M 25/04 (2006.01); A61M 25/09 (2006.01); A61M 25/10 (2013.01)
CPC A61B 17/3403 (2013.01) [A61B 17/22031 (2013.01); A61B 17/221 (2013.01); A61B 17/32075 (2013.01); A61B 17/320758 (2013.01); A61B 17/3415 (2013.01); A61B 17/3417 (2013.01); A61B 17/3476 (2013.01); A61F 2/88 (2013.01); A61M 25/0074 (2013.01); A61M 25/04 (2013.01); A61M 25/10 (2013.01); A61B 17/00008 (2013.01); A61B 2017/00252 (2013.01); A61B 2017/003 (2013.01); A61B 2017/00455 (2013.01); A61B 2017/00685 (2013.01); A61B 2017/22034 (2013.01); A61B 2017/22038 (2013.01); A61B 2017/22044 (2013.01); A61B 2017/22077 (2013.01); A61B 2017/22094 (2013.01); A61B 2017/22095 (2013.01); A61B 2017/2212 (2013.01); A61B 2017/320004 (2013.01); A61B 2017/320044 (2013.01); A61B 2017/320064 (2013.01); A61B 17/32053 (2013.01); A61B 2017/320741 (2013.01); A61B 2017/3405 (2013.01); A61B 2017/3454 (2013.01); A61M 25/003 (2013.01); A61M 25/0032 (2013.01); A61M 25/0045 (2013.01); A61M 2025/006 (2013.01); A61M 25/0069 (2013.01); A61M 25/007 (2013.01); A61M 25/0082 (2013.01); A61M 25/0152 (2013.01); A61M 2025/018 (2013.01); A61M 2025/09175 (2013.01); A61M 2025/09191 (2013.01); A61M 2025/105 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A system for bypassing an occlusion in a blood vessel, comprising:
an intramural orienting device comprising:
an elongate shaft including a lumen extending therein to a distally facing opening at a distal end of the elongate shaft; and
an orienting element including two wings configured to shift between a collapsed delivery configuration and an expanded deployed configuration, the two wings being monolithically formed with a portion of the elongate shaft;
wherein in the expanded deployed configuration, the two wings extend outwardly from the elongate shaft in a substantially planar manner;
wherein a distal portion of the elongate shaft includes a side opening in communication with the lumen, the side opening facing orthogonally relative to the two wings.